BaTeLab Co., Ltd. (2149) AI Stock Analysis

• Market Cap: HK$3.39B
• Dividend Yield: N/A
• Average Volume (3M): 263.27K
• Price to Earnings (P/E): 17.0
• Beta (1Y): 0.14
• Revenue Growth: 5.19%
• EPS Growth: N/A
• Country: HK
• Employees: 116
• Sector: General
• Sector Strength: N/A
• Industry: Semiconductors
• EPS (TTM): 1.38
• Shares Outstanding: 18,000,000
• 10 Day Avg. Volume: 238,450
• 30 Day Avg. Volume: 263,268
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: HK$93.00
• Price Target Upside: 72.86% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 1

• Rating: 68 Neutral
• Price Target: HK$59.00 ▲(9.67% Upside)

The overall stock score is primarily driven by strong financial performance, despite challenges in cash flow management. Technical analysis indicates a bearish trend, which is a concern. Valuation is reasonable, but the lack of a dividend yield may deter some investors.

Positive Factors

Revenue Growth

The company's strong revenue growth indicates robust market demand and successful product adoption, supporting long-term business expansion.

Market Position

Strategic partnerships bolster BaTeLab's market position, increasing credibility and access to new markets, which is crucial for sustained growth.

Balance Sheet Health

A strong balance sheet with a favorable equity ratio provides financial stability, allowing the company to invest in growth opportunities.

Negative Factors

Cash Flow Management

Difficulty in generating positive free cash flow may limit BaTeLab's ability to fund operations and investments, impacting long-term financial health.

Debt Levels

Rising debt levels could strain financial resources, potentially affecting the company's ability to invest in growth and innovation.

Dividend Policy

The lack of a dividend yield may deter income-focused investors, potentially impacting the company's attractiveness to a broader investor base.

BaTeLab Co., Ltd. Business Overview & Revenue Model

Company Description

BaTeLab Co., Ltd. engages in the research, development, and sale of analog integrated circuit (IC) patterned wafers used in packaging and testing solutions in China. It offers power management products, including AC-DC and DC-DC switching regulators, multi-channel ICs and PMICs, linear regulators, battery management ICs, monitoring and modulating ICs, and driver ICs. The company also provides signal chain products, such as linear products. Its products are used in industries and fields, including automotive electronics, healthcare, industrial automation, industrial Internet of Things, industrial lighting, instrumentation, communications, electric power, energy storage, and consumer electronics. BaTeLab Co., Ltd. was incorporated in 2010 and is headquartered in Suzhou, China.

How the Company Makes Money

BaTeLab Co., Ltd. generates revenue through multiple channels, primarily by selling its proprietary pharmaceutical products and medical devices to healthcare institutions and directly to consumers. The company also earns income from licensing its technologies and patents to other firms in the biotechnology sector. Additionally, BaTeLab has established strategic partnerships with major healthcare providers and research institutions, which enhance its market reach and credibility. Grants and funding from governmental and non-governmental organizations for research and development projects further contribute to its earnings, allowing the company to innovate and expand its product portfolio.

BaTeLab Co., Ltd. Financial Statement Overview

Summary

BaTeLab Co., Ltd. shows strong revenue growth and profitability with a solid balance sheet. However, cash flow management needs improvement, particularly in generating positive free cash flow.

Income Statement

BaTeLab Co., Ltd. has demonstrated strong revenue growth with a significant increase from the previous year, indicating robust market demand. The gross profit margin is healthy, and the net profit margin has improved, reflecting efficient cost management. The EBIT and EBITDA margins are also solid, showcasing operational efficiency. Overall, the income statement reflects a positive growth trajectory and profitability.

Balance Sheet

The balance sheet of BaTeLab Co., Ltd. shows a strong equity position with a favorable equity ratio, indicating financial stability. The debt-to-equity ratio is moderate, suggesting manageable leverage levels. Return on equity is impressive, highlighting effective utilization of equity capital. However, the increase in total debt warrants monitoring to ensure it remains within sustainable levels.

Cash Flow

BaTeLab Co., Ltd. has experienced challenges in generating positive free cash flow, which is a concern despite positive operating cash flow. The free cash flow to net income ratio is negative, indicating potential issues in converting earnings into cash. However, the operating cash flow to net income ratio is positive, suggesting that operational activities are generating cash, albeit not enough to cover capital expenditures.

Breakdown	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	578.81M	463.88M	409.93M	256.36M	99.69M
Gross Profit	306.92M	257.11M	231.79M	144.63M	54.78M
EBITDA	144.94M	119.02M	101.89M	63.53M	19.35M
Net Income	166.60M	109.16M	95.26M	56.97M	13.99M
Balance Sheet
Total Assets	1.61B	1.27B	668.62M	435.55M	203.52M
Cash, Cash Equivalents and Short-Term Investments	636.02M	550.84M	206.20M	179.55M	80.02M
Total Debt	325.22M	182.63M	189.97M	45.13M	24.06M
Total Liabilities	603.81M	432.70M	224.20M	67.87M	163.43M
Stockholders Equity	1.01B	838.23M	444.42M	367.68M	40.08M
Cash Flow
Free Cash Flow	-20.34M	-13.40M	-34.68M	-33.62M	-54.21M
Operating Cash Flow	13.56M	30.28M	-12.91M	10.03M	-47.71M
Investing Cash Flow	-63.95M	-41.70M	-18.58M	53.80M	-5.21M
Financing Cash Flow	127.56M	400.68M	49.78M	96.88M	53.69M

BaTeLab Co., Ltd. Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 53.80
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:2149, the sentiment is Negative. The current price of 53.8 is below the 20-day moving average (MA) of 54.08, below the 50-day MA of 57.09, and above the 200-day MA of 45.83, indicating a neutral trend. The MACD of -0.76 indicates Negative momentum. The RSI at 44.56 is Neutral, neither overbought nor oversold. The STOCH value of 26.75 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:2149.

BaTeLab Co., Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
1385	77 Outperform	HK$49.34B	76.00	9.71%	0.21%	2.33%	-32.82%
2149	68 Neutral	HK$3.39B	16.99	16.76%	―	5.19%	―
0085	64 Neutral	HK$3.15B	7.55	24.05%	5.81%	-18.35%	-6.00%
2878	61 Neutral	HK$1.40B	27.05	7.39%	―	-25.16%	-51.97%
1347	51 Neutral	HK$133.08B	284.02	0.93%	0.24%	―	―
8490	48 Neutral	HK$136.16M	-1.80	-24.97%	―	-26.02%	-4977.27%
Sector *	55 Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%

BaTeLab Co., Ltd. Corporate Events

BaTeLab Co., Ltd. Reports 14.9% Increase in Profit for First Half of 2025

BaTeLab Co., Ltd., a joint stock company incorporated in the People’s Republic of China, has announced its interim results for the six months ending June 30, 2025. The company reported a modest revenue increase of 0.4% to RMB291.7 million, with a gross profit rise of 1.4% to RMB151.0 million. Notably, the profit before taxation surged by 14.9% to RMB77.1 million. Despite these gains, the board has decided not to recommend an interim dividend for this period.

The most recent analyst rating on (HK:2149) stock is a Buy with a HK$65.00 price target. To see the full list of analyst forecasts on BaTeLab Co., Ltd. stock, see the HK:2149 Stock Forecast page.

BaTeLab Co., Ltd. Schedules Board Meeting for Interim Results

BaTeLab Co., Ltd. has announced that its board of directors will hold a meeting on August 22, 2025, to consider and approve the interim results for the first half of the year ending June 30, 2025. This meeting is significant as it will determine the company’s financial performance for the period and could impact its market positioning and stakeholder interests.

BaTeLab Co., Ltd. Announces Key Leadership Changes

BaTeLab Co., Ltd. announced significant changes in its corporate governance structure, including the resignation of Mr. Cheung Kai Cheong Willie as joint company secretary and the appointment of Mr. Chung Ming Fai in his place, effective July 3, 2025. Additionally, Mr. Zhang Guangping has been elected as the chairman of the board and authorized representative, reflecting a strategic move to strengthen the company’s leadership and compliance framework.

BaTeLab Co., Ltd. Announces Board Composition and Roles

BaTeLab Co., Ltd., a joint stock company incorporated in the People’s Republic of China, has announced the composition of its board of directors and their respective roles within the company’s committees. The announcement details the executive, non-executive, and independent non-executive directors, highlighting the leadership roles within the audit, remuneration and evaluation, nomination, and strategy committees. This organizational update may impact the company’s governance and strategic direction, potentially influencing stakeholder confidence and market perception.

BaTeLab Co., Ltd. Forms Nomination Committee to Strengthen Governance

BaTeLab Co., Ltd. has announced the establishment of a Nomination Committee by its board of directors. This committee will consist of at least three members, with a majority being independent non-executive directors, and will include at least one director of a different gender. The committee’s formation is a strategic move to enhance corporate governance, ensuring diverse and independent oversight in the company’s nomination processes, which could positively impact stakeholder confidence and the company’s industry positioning.

BaTeLab Co., Ltd. Successfully Concludes AGM with Unanimous Approval of Resolutions

BaTeLab Co., Ltd., a company based in the People’s Republic of China, successfully held its Annual General Meeting (AGM) on June 27, 2025, where all proposed resolutions were approved by the shareholders. The meeting, attended by shareholders holding approximately 66.54% of the total issued shares, resulted in unanimous approval of key resolutions including the 2024 annual report, audited financial statements, and the appointment of auditors for 2025. The AGM was conducted in compliance with the relevant legal and regulatory requirements, with no shareholders abstaining or voting against the resolutions.